Antibiotic Treatment for Infected Foot Cut in a 28kg Child
For a 28kg child with an infected cut on the bottom of the foot, cephalexin at a dose of 25-50 mg/kg/day divided into 4 doses (approximately 175-350 mg four times daily) is the most appropriate first-line antibiotic therapy. 1
First-Line Treatment Options
Beta-lactam antibiotics
Cephalexin: 25-50 mg/kg/day in 4 divided doses (175-350 mg four times daily)
- First-line oral agent for uncomplicated skin and soft tissue infections
- Effective against methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus species
- Suitable for penicillin-allergic patients except those with immediate hypersensitivity reactions
- Available as suspension, making it practical for pediatric use 1
Dicloxacillin: 25-50 mg/kg/day in 4 divided doses
- Alternative oral agent for MSSA
- Less commonly used in pediatrics 1
Alternative Options (if MRSA is suspected or confirmed)
If community-acquired methicillin-resistant S. aureus (CA-MRSA) is suspected based on local prevalence patterns or previous history:
Clindamycin: 30-40 mg/kg/day in 3 divided doses (approximately 280-370 mg three times daily)
- Important option for children with suspected MRSA
- Caution: potential for cross-resistance in erythromycin-resistant strains 1
Trimethoprim-sulfamethoxazole (TMP-SMX): 8-12 mg/kg/day based on trimethoprim component in 2 divided doses
- Effective against MRSA
- Note: Less effective for streptococcal infections, which may be present in foot wounds 2
Treatment Duration
- Treatment duration should be approximately 7 days, depending on clinical response 1
- For deeper or more severe infections, longer courses may be necessary
Assessment Factors to Consider
When evaluating the infected foot wound:
Severity of infection:
- Presence of surrounding erythema, warmth, tenderness
- Extent of cellulitis beyond the wound
- Presence of purulent drainage
Risk factors for MRSA:
- Local prevalence of MRSA
- Previous MRSA infections
- Recent antibiotic use
Location considerations:
- Foot wounds may have higher risk of gram-negative and polymicrobial infections
- Consider broader coverage if deeper infection is suspected
Important Caveats
- Drainage: If abscess formation is present, incision and drainage is essential for treatment success 3
- MRSA consideration: In areas with high MRSA prevalence, consider MRSA coverage if the infection appears more severe or fails to respond to initial beta-lactam therapy
- Monitoring: Re-evaluate within 48-72 hours to ensure appropriate response to therapy
- Tetracyclines: Doxycycline is not recommended for children under 8 years of age 1
- Foot location: The plantar surface of the foot may be subject to more contamination and different bacterial profiles than other skin locations
Treatment Failure
If no improvement after 48-72 hours of initial therapy:
- Consider wound culture and sensitivity testing
- Reassess need for drainage procedure
- Consider switching to alternative antibiotic with different coverage spectrum
- Evaluate for deeper infection requiring more aggressive management
Beta-lactams remain appropriate first-line therapy even in regions with endemic CA-MRSA for uncomplicated skin infections 2, but close follow-up is essential to identify treatment failures early.